Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001225208-13-011735)

Filing Details

Accession Number:
0001225208-13-011735
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-08 19:29:00
Reporting Period:
2013-05-06
Filing Date:
2013-05-08
Accepted Time:
2013-05-08 19:29:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
310158 Merck & Co. Inc. MRK Pharmaceutical Preparations (2834) 221918501
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1485616 P Bridgette Heller One Merck Drive
Whitehouse Station NJ 08889-0100		 Exe.vp & Pres.con.hlth.care No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-07 60,024 $33.49 67,266 No 4 M Direct
Common Stock Acquisiton 2013-05-07 29,860 $0.00 97,126 No 4 M Direct
Common Stock Disposition 2013-05-07 15,483 $44.98 81,643 No 4 F Direct
Common Stock Disposition 2013-05-07 54,532 $45.08 27,111 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2013-05-06 70,853 $0.00 70,853 $44.98
Common Stock Restricted Stock Unit Disposition 2013-05-07 29,860 $44.98 29,860 $0.00
Common Stock Stock Option (right to buy) Disposition 2013-05-07 60,024 $0.00 60,024 $33.49
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
70,853 2014-05-06 2023-05-05 No 4 A Direct
0 2013-05-07 2013-05-07 No 4 M Direct
0 2011-05-07 2020-05-06 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.0500 to $45.1300, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
  2. Holdings include shares acquired in dividend reinvestment transactions.
  3. The option vests in three equal annual installments beginning May 6, 2014.
  4. Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.